PHOEBE SUMTER MEDICAL CENTER — History
CCN 110044 | 3-year financial timeline | COVID resilience: 73/100
🛡️ Public data only — no PHI permitted on this instance.
$101M
Latest Revenue (FY2022)
+6.9%
Revenue CAGR (3yr)
-1.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $88M | $97M | $101M | +4.2% | +6.9% |
| Operating Expenses | $97M | $105M | $103M | -2.2% | +2.8% |
| Operating Margin | -10.0% | -8.3% | -1.6% | +80.3% | +0.0% |
| Net Income | $-9M | $-8M | $-2M | +79.4% | +0.0% |
| Licensed Beds | 54 | 54 | 54 | +0.0% | +0.0% |
| Total Patient Days | 13,483 | 16,330 | 16,916 | +3.6% | +12.0% |
| Medicare Day % | 22% | 19% | 17% | -14.0% | -12.4% |
| Medicaid Day % | 12% | 12% | 12% | +1.7% | +2.8% |
COVID Impact & Recovery
Resilience Score: 73/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +14.4% ($88M → $101M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.9%
This Hospital
+7.6%
State Avg
Latest Margin
-1.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $107M | 2.6% |
| FY2024 (proj) | $114M | 6.8% |
| FY2025 (proj) | $120M | 11.0% |